News
In a significant leap forward for successful cancer surgery, researchers at the University of Missouri and collaborators have ...
ProCure Proton Therapy Center reminds area residents about the critical importance to men of prostate-specific antigen (PSA) screenings for prostate cancer. Early detection through this simple blood ...
Northwestern Medicine scientists have uncovered key details about a group of rare but serious blood disorders, which may help inform potential treatments, according to a study published in the Journal ...
In an interview with Targeted OncologyTM, Ravi Muvner, MD, urologist at Hackensack University Medical Center, discusses how targeted therapies have changed the landscape of prostate cancer treatment.
Vlad Vitoc, M.D., is Chairman of Board, Chief Executive Officer, and President of MAIA Biotechnology Inc. Dr. Vitoc has a ...
FDA approved to help select patients with metastatic prostate cancer for radioligand therapy before chemotherapy.
A breakthrough test can successfully predict whether chemotherapy will work so patients can avoid needless side effects. The ...
Veteran news presenter Dermot Murnaghan has revealed he is living with stage 4 prostate cancer.The broadcaster, who anchored ...
Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, ...
A combination featuring Exelixis’ experimental drug zanzalintinib has beaten Bayer’s gastrointestinal cancer med Stivarga in ...
Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”, “the Company”) today announces that the United States (U.S.) ...
The reply is no, they don’t, unless the latrines are downright germ havens. At the screening, organised by the regional ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results